Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigations

Anti–Prostate-Specific Membrane Antigen Liposomes Loaded with 225Ac for Potential Targeted Antivascular α-Particle Therapy of Cancer

Amey Bandekar, Charles Zhu, Rohit Jindal, Frank Bruchertseifer, Alfred Morgenstern and Stavroula Sofou
Journal of Nuclear Medicine January 2014, 55 (1) 107-114; DOI: https://doi.org/10.2967/jnumed.113.125476
Amey Bandekar
1Departments of Chemical and Biochemical Engineering and Biomedical Engineering, Rutgers University, Piscataway, New Jersey; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Zhu
1Departments of Chemical and Biochemical Engineering and Biomedical Engineering, Rutgers University, Piscataway, New Jersey; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rohit Jindal
1Departments of Chemical and Biochemical Engineering and Biomedical Engineering, Rutgers University, Piscataway, New Jersey; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Bruchertseifer
2Alpha-Immunotherapy, European Commission, Joint Research Centre, Institute for Transuranium Elements, Karlsruhe, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfred Morgenstern
2Alpha-Immunotherapy, European Commission, Joint Research Centre, Institute for Transuranium Elements, Karlsruhe, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stavroula Sofou
1Departments of Chemical and Biochemical Engineering and Biomedical Engineering, Rutgers University, Piscataway, New Jersey; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 55 no. 1 107-114
DOI 
https://doi.org/10.2967/jnumed.113.125476
PubMed 
24337602

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication September 10, 2013
  • Accepted for publication September 24, 2013
  • Published online January 2, 2014.

Article Versions

  • previous version (December 12, 2013 - 06:21).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Amey Bandekar1,
  2. Charles Zhu*,1,
  3. Rohit Jindal*,1,
  4. Frank Bruchertseifer2,
  5. Alfred Morgenstern2 and
  6. Stavroula Sofou1
  1. 1Departments of Chemical and Biochemical Engineering and Biomedical Engineering, Rutgers University, Piscataway, New Jersey; and
  2. 2Alpha-Immunotherapy, European Commission, Joint Research Centre, Institute for Transuranium Elements, Karlsruhe, Germany
  1. For correspondence or reprints contact: Stavroula Sofou, Departments of Chemical and Biochemical Engineering and Biomedical Engineering, Rutgers University, 599 Taylor Road, Piscataway, NJ 08854. E-mail: ss1763{at}rci.rutgers.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 89 Citations
  • 87 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Aptamer-based targeted therapy
    Guizhi Zhu, Xiaoyuan Chen
    Advanced Drug Delivery Reviews 2018 134
  • Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
    Fadwa Odeh, Hamdi Nsairat, Walhan Alshaer, Mohammad A. Ismail, Ezaldeen Esawi, Baraa Qaqish, Abeer Al Bawab, Said I. Ismail
    Molecules 2019 25 1
  • Radiolabelling of nanomaterials for medical imaging and therapy
    Juan Pellico, Peter J. Gawne, Rafael T. M. de Rosales
    Chemical Society Reviews 2021 50 5
  • Aptamer-functionalized liposomes for targeted cancer therapy
    Seyedeh Alia Moosavian, Amirhossein Sahebkar
    Cancer Letters 2019 448
  • Multifunctional nanoparticles: recent progress in cancer therapeutics
    G. Seeta Rama Raju, Leah Benton, E. Pavitra, Jae Su Yu
    Chemical Communications 2015 51 68
  • Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine
    Francis Man, Peter J. Gawne, Rafael T.M. de Rosales
    Advanced Drug Delivery Reviews 2019 143
  • RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo
    Si Eun Baek, Kwang Hyun Lee, Yong Serk Park, Deok-Kun Oh, Sangtaek Oh, Keun-Sik Kim, Dong-Eun Kim
    Journal of Controlled Release 2014 196
  • Evaluation of an Anti-HER2 Nanobody Labeled with 225Ac for Targeted α-Particle Therapy of Cancer
    Marek Pruszynski, Matthias D’Huyvetter, Frank Bruchertseifer, Alfred Morgenstern, Tony Lahoutte
    Molecular Pharmaceutics 2018 15 4
  • The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease
    James C Evans, Meenakshi Malhotra, John F Cryan, Caitriona M O'Driscoll
    British Journal of Pharmacology 2016 173 21
  • Targeted Radionuclide Therapy of Prostate Cancer—From Basic Research to Clinical Perspectives
    Malwina Czerwińska, Aleksander Bilewicz, Marcin Kruszewski, Aneta Wegierek-Ciuk, Anna Lankoff
    Molecules 2020 25 7

Article usage

Article usage: December 2013 to April 2025

AbstractFullPdf
Dec 2013266044
Jan 20149963088
Feb 20142922233
Mar 20142323358
Apr 20142371211
May 20141891011
Jun 20141631820
Jul 20141254450
Aug 2014922427
Sep 20141113038
Oct 2014853150
Nov 2014873027
Dec 20141052925
Jan 2015992327
Feb 20151062641
Mar 20151305122
Apr 2015583021
May 2015832621
Jun 2015663822
Jul 2015623526
Aug 2015692422
Sep 2015452021
Oct 2015412812
Nov 2015633014
Dec 2015612316
Jan 2016673121
Feb 2016332425
Mar 2016342426
Apr 2016412334
May 2016341417
Jun 2016562420
Jul 2016211818
Aug 2016331519
Sep 2016382235
Oct 2016431636
Nov 2016272023
Dec 2016261723
Jan 2017312014
Feb 2017393527
Mar 2017402221
Apr 2017283222
May 2017411721
Jun 2017313021
Jul 2017282420
Aug 2017431517
Sep 2017251523
Oct 2017422117
Nov 2017401415
Dec 2017211820
Jan 2018341816
Feb 2018381519
Mar 2018281519
Apr 2018142016
May 2018141410
Jun 201813116
Jul 2018101019
Aug 201812127
Sep 2018101010
Oct 2018121611
Nov 201818714
Dec 2018111811
Jan 2019231214
Feb 2019291415
Mar 2019242621
Apr 2019161921
May 2019281517
Jun 201921928
Jul 201921915
Aug 201923810
Sep 2019161111
Oct 2019232319
Nov 2019301518
Dec 2019192229
Jan 202018510
Feb 2020231317
Mar 2020271021
Apr 202018715
May 202023411
Jun 2020231513
Jul 20201164
Aug 2020121215
Sep 20201588
Oct 2020251016
Nov 2020311012
Dec 2020171413
Jan 202193130
Feb 2021122923
Mar 202173523
Apr 202134518
May 202153519
Jun 2021112916
Jul 202172712
Aug 202174010
Sep 202163513
Oct 202184636
Nov 202182924
Dec 202154712
Jan 2022154329
Feb 2022123513
Mar 202293428
Apr 202234123
May 202242233
Jun 202223013
Jul 202210409
Aug 202253317
Sep 202283122
Oct 202272516
Nov 202283321
Dec 202232611
Jan 2023134426
Feb 202392921
Mar 202364621
Apr 2023143921
May 202393415
Jun 202343120
Jul 2023103223
Aug 202333112
Sep 202362710
Oct 202335720
Nov 2023136533
Dec 20231213923
Jan 20241062153
Feb 202464915
Mar 202436236
Apr 2024914326
May 202467334
Jun 202476319
Jul 2024168024
Aug 2024137026
Sep 2024103325
Oct 2024114324
Nov 2024104019
Dec 202495117
Jan 202524525
Feb 20251017727
Mar 2025610242
Apr 20251110650
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 55 (1)
Journal of Nuclear Medicine
Vol. 55, Issue 1
January 1, 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Anti–Prostate-Specific Membrane Antigen Liposomes Loaded with 225Ac for Potential Targeted Antivascular α-Particle Therapy of Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Anti–Prostate-Specific Membrane Antigen Liposomes Loaded with 225Ac for Potential Targeted Antivascular α-Particle Therapy of Cancer
Amey Bandekar, Charles Zhu, Rohit Jindal, Frank Bruchertseifer, Alfred Morgenstern, Stavroula Sofou
Journal of Nuclear Medicine Jan 2014, 55 (1) 107-114; DOI: 10.2967/jnumed.113.125476

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Anti–Prostate-Specific Membrane Antigen Liposomes Loaded with 225Ac for Potential Targeted Antivascular α-Particle Therapy of Cancer
Amey Bandekar, Charles Zhu, Rohit Jindal, Frank Bruchertseifer, Alfred Morgenstern, Stavroula Sofou
Journal of Nuclear Medicine Jan 2014, 55 (1) 107-114; DOI: 10.2967/jnumed.113.125476
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial Analogues
  • Google Scholar

More in this TOC Section

  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
Show more Basic Science Investigations

Similar Articles

Keywords

  • anti-PSMA liposomes
  • liposomal 225Ac
  • antivascular α-particle radiotherapy
SNMMI

© 2025 SNMMI

Powered by HighWire